Definitive Contract HR001111C0095

This federal contract was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Genscript USA Inc., a biotechnology company, for protein antigen production services in support of influenza vaccine research. The $129,035.82 firm-fixed-price purchase order does not have a set-aside designation. The services provided by Genscript under this contract include gene synthesis, protein expression, and purification of influenza vaccine...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $849,451 firm fixed price delivery order to Protein Sciences Corporation under the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The delivery order is for the manufacture of master/working seed lot(s), research lot(s), and analytical laboratory testing/assay(s) to be performed in Meriden, Connecticut through June 2021. No subcontractors or set aside...

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $29.9 million delivery order to Protein Sciences Corporation under the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The delivery order is for non-clinical and Phase I clinical studies of a stabilized pre-fusion trimer of the spike protein COVID-19 vaccine candidate reconstituted with two adjuvants, AS03 and AF03, to be performed in Meriden,...

This federal contract award to Protein Sciences Corp from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, is for the research and development of a protein antigen in support of pandemic influenza preparedness and response. The contract has a Firm Fixed Price of $6,425.00 and was designated as a Total Small Business set-aside. Protein Sciences Corp, a for-profit manufacturer, has received multiple prior contract...

This contract is for regulatory support services related to clinical studies and testing of chimeric antigens for influenza viruses H5/H1N1 and H8/H1N1. The contract was awarded to Seqirus USA Inc., a global biotechnology company that specializes in the development and delivery of influenza vaccines. The contract has a ceiling value of $48,000.00 and was awarded on August 14, 2015 by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department...

The Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response awarded Protein Sciences Corporation a $125,260 firm fixed price delivery order against the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. This order calls for Protein Sciences to conduct storage and stability testing of antigen final containers in the National Pre-Pandemic Vaccine Stockpile. Specifically, the contractor will test RH7 A Guangdong final...

Palogen, Inc. was awarded a definitive, firm fixed price contract valued at one million five hundred thousand dollars ($1,500,000) by the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering. The contract is to develop Palogen's innovative ultra-fast chip technology for COVID-19 RNA detection under Project Number 13139. Work will be performed in South Korea through September 2023. No set-aside designation was applied to this award to the for-profit...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $14.8 million firm fixed price purchase order to Hologic, Inc. to deliver its respiratory panel test for SARS-CoV, influenza A, influenza B, and RSV. The test will be used on Hologic's Panther Fusion system. The contract supports the agency's coronavirus COVID-19 response efforts and requires performance in San Diego, California over a base period ending in September 2022. No set...

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $49,157 delivery order against the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ to Protein Sciences Corporation of Meriden, Connecticut. The firm fixed price order is for claims and will be performed from September 30, 2019 through September 30, 2019 in Meriden, Connecticut. The Pandemic Influenza Preparedness and Response master IDIQ, valued at over $49...

This is a $35,019,405.00 firm fixed-price delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a foreign-owned, for-profit biotechnology company that specializes in pandemic preparedness and response. The purpose of the contract is to procure an influenza A(H2Nx) virus vaccine candidate(s) and conduct related clinical trials. This order is part of a larger $13.4 billion...